FIELD: medicine.
SUBSTANCE: invention relates to experimental medicine, namely to gynecology, and can be used for correction of failures in reproductive organs, caused by carrying out controlled total-body hyperthermia (CTBH). For this purpose, after CTBH impact melatonin is introduced into animal organism.
EFFECT: method ensures prevention of spasm of ovarian arteries; reduction of venous congestion severity and normalisation of venous blood flow; reduction of severity of lymph flow and folliculogenesis failures on the 7-th day; as well as ensures restoration of volume density of yellow bodies of ovaries, which are at the proliferation and vascularisation stage; reduction of degree of severity of decrease of volume density of ovary yellow bodies that are at the stages of glandular metamorphosis and growth; reduction of degree of severity of degeneration and atresia of yellow bodies that are at the stage of reverse development.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REGULATING REPRODUCTIVE FUNCTION IN COWS | 2005 |
|
RU2286057C2 |
| METHOD FOR MODELING POLYCYSTIC OVARIES AT PREDOMINANCE OF FOLLICULAR CYSTS | 2005 |
|
RU2282249C1 |
| USING INTRAVAGINAL INSULIN SENSITISERS | 2010 |
|
RU2567334C2 |
| MEANS FOR CORRECTION OF OVARY DAMAGE CAUSED BY CYTOSTATIC EFFECT | 2021 |
|
RU2785397C1 |
| METHOD FOR CORRECTING AGE-RELATED NEUROENDOCRINE REGULATION EXPERIMENTALLY | 2014 |
|
RU2568366C1 |
| METHOD FOR MODELING PRO-CARCINOGENIC EFFECT OF SYNOESTROL ON THE OVARIES OF THE FEMALE OFFSPRING OF LABORATORY MICE | 2018 |
|
RU2676437C1 |
| METHOD FOR MODELLING SUPPRESSION OF OVARIAN HORMONAL ACTIVITY | 1999 |
|
RU2191584C2 |
| DIAGNOSTIC TECHNIQUE FOR REPRODUCTIVE OVARIAN POTENCY | 2008 |
|
RU2367949C1 |
| AGENT FOR TREATING FEMALE INFERTILITY AND INFERTILITY OF FEMALE ANIMALS | 2017 |
|
RU2740922C2 |
| METHOD OF FINDING GRANULOSE IN HISTOLOGICAL PREPARATIONS OF SCLERO-CYSTIC OVARIES OF WOMAN | 1991 |
|
RU2031407C1 |
